Success Metrics

Clinical Success Rate
86.0%

Based on 129 completed trials

Completion Rate
86%(129/150)
Active Trials
9(5%)
Results Posted
36%(47 trials)
Terminated
21(11%)

Phase Distribution

Ph early_phase_1
1
1%
Ph phase_1
11
6%
Ph phase_2
52
27%
Ph phase_3
55
29%
Ph phase_4
37
19%
Ph not_applicable
26
14%

Phase Distribution

12

Early Stage

52

Mid Stage

92

Late Stage

Phase Distribution182 total trials
Early Phase 1First-in-human
1(0.5%)
Phase 1Safety & dosage
11(6.0%)
Phase 2Efficacy & side effects
52(28.6%)
Phase 3Large-scale testing
55(30.2%)
Phase 4Post-market surveillance
37(20.3%)
N/ANon-phased studies
26(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.3%

129 of 153 finished

Non-Completion Rate

15.7%

24 ended early

Currently Active

9

trials recruiting

Total Trials

192

all time

Status Distribution
Active(16)
Completed(129)
Terminated(24)
Other(23)

Detailed Status

Completed129
unknown23
Terminated21
Recruiting8
Not yet recruiting7
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
192
Active
9
Success Rate
86.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.5%)
Phase 111 (6.0%)
Phase 252 (28.6%)
Phase 355 (30.2%)
Phase 437 (20.3%)
N/A26 (14.3%)

Trials by Status

withdrawn32%
active_not_recruiting11%
completed12967%
not_yet_recruiting74%
recruiting84%
terminated2111%
unknown2312%

Recent Activity

Clinical Trials (192)

Showing 20 of 192 trialsScroll for more
NCT07716332Not Applicable

Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism Prophylaxis

Not Yet Recruiting
NCT07710482Not Applicable

Prophylactic Anticoagulation for Central Venous Line Insertion in Critically Ill Children

Not Yet Recruiting
NCT07015905Phase 3

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Recruiting
NCT07599384

Emulation of the RECORD3 Trial Using Healthcare Claims Data

Completed
NCT07312851Phase 1

A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

Completed
NCT05083455

Replication of the RECORD1 Anticoagulant Trial in Healthcare Claims Data

Completed
NCT06243510Not Applicable

Comparison of Apixaban Versus Enoxaparin

Completed
NCT04924322Phase 2

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Recruiting
NCT06454630Phase 2

A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants

Completed
NCT06628778Phase 3

Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).

Not Yet Recruiting
NCT07559643Not Applicable

The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.

Not Yet Recruiting
NCT06517563Phase 1

Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin

Completed
NCT07462182Not Applicable

Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction

Not Yet Recruiting
NCT07140523Phase 2

A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA

Recruiting
NCT05255003Phase 4

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Recruiting
NCT01588171Not Applicable

Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum

Completed
NCT05203705Phase 2

Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty

Terminated
NCT07189897Phase 4

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

Recruiting
NCT06180889Phase 2

Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Active Not Recruiting
NCT06118957Phase 2

Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery

Completed

Drug Details

Intervention Type
DRUG
Total Trials
192